Neuroprotection on Multiple Sclerosis: A BDNF Perspective

Journal of Neurology & Neurophysiology
doi 10.4172/2155-9562.1000e108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Oligodendrocyte Regeneration: Its Significance in Myelin Replacement and Neuroprotection in Multiple Sclerosis

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2016English

Plasma Brain-Derived Neurotrophic Factor (BDNF) and Sphingosine-1-Phosphat (S1P) Are NOT the Main Mediators of Neuroprotection Induced by Resistance Training in Persons With Multiple Sclerosis - A Randomized Controlled Trial

Multiple Sclerosis and Related Disorders
MedicineNeurology
2019English

Introductory Chapter: Concept of Neuroprotection - A New Perspective

2019English

A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis

Frontiers in Neurology
Neurology
2019English

Multiple Sclerosis - A Review

European Journal of Neurology
Neurology
2018English

Multiple Sclerosis: A Reappraisal

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1973English

Multiple Sclerosis: A Reappraisal

Neurology
Neurology
1966English

Multiple Sclerosis: A Review

BMJ
1973English

Multiple Sclerosis—a Quiet Revolution

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy